Search results
Wegovy maker Novo Nordisk extends losses following first-quarter results
CNBC· 3 days agoShares of Danish pharmaceutical giant Novo Nordisk slid 2.5% on Friday, extending a 2.7% loss on...
Wegovy maker Novo Nordisk down 4%, heads for worst day since October
NBC Dallas Fort Worth· 3 days agoShares of Danish pharmaceutical giant Novo Nordisk slid 4% on Friday, extending a 2.7% loss on...
Weight-loss drug maker Novo Nordisk's profits soar further
AFP via Yahoo Finance· 4 days agoDanish pharmaceutical giant Novo Nordisk reported more soaring profits on Thursday thanks to the...
This Is a Huge Sigh of Relief for Novo Nordisk Investors
Motley Fool via Yahoo Finance· 3 days agoNovo Nordisk's (NYSE: NVO) success hinges on two key products: Ozempic and Wegovy. The former is a...
Global health heavyweights team up for climate, disease funding
Reuters via AOL· 13 hours agoThree of the biggest global health funders have joined forces for the first time in a $300 million...
Ozempic maker Novo Nordisk denies flooding market with 'junk' patents after FTC challenge
Quartz· 4 days agoNovo Nordisk responded today to the U.S. Federal Trade Commission’s (FTC) suggestion that it filed...
Novo Nordisk announces $6B investment in Ozempic, Wegovy amid shortages
Good Morning America via Yahoo News· 4 days agoNovo Nordisk, the maker of popular drugs used for weight loss including Ozempic and Wegovy, says it...
Novo Nordisk Dips After Wegovy Sales Double, But Miss Analysts' Forecast
Investor's Business Daily· 4 days agoNovo Nordisk stock sank Thursday after sales of weight-loss blockbuster, Wegovy, nearly doubled year...
Novo Nordisk announces $6B investment in Ozempic, Wegovy amid shortages
ABC News· 4 days agoAn executive for Novo Nordisk, the maker of popular drugs used for weight loss including Ozempic and...
Novo Nordisk (NVO) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 4 days agoImage source: The Motley Fool. Novo Nordisk (NYSE: NVO) Q1 2024 Earnings Call May 02, 2024, 7:00 a.m. ET Contents: Prepared Remarks Questions and Answers...